11 | $TKOI News Article - Telkonet Signs Stock | whytestocks | 08/09/2021 10:00:45 AM |
10 | $TKOI News Article - Telkonet, Inc. and | whytestocks | 03/08/2021 8:50:47 AM |
9 | TKOI 32% v1,2M c.0379 f136M | znewcar1 | 11/27/2020 2:35:41 PM |
8 | Telkonet, Inc. (OTCQB: TKOI) has far bigger and | Uptick Network | 08/03/2016 1:42:35 PM |
7 | TKOI Financials 07/15/2014 23:06:09 Telkonet, | Emylers | 07/16/2014 12:06:06 AM |
6 | Glad you liked it. thanks | Stock_Tracker | 03/12/2014 8:50:57 PM |
5 | Nice post although there are a couple erroneous | littlbyrdy | 03/11/2014 8:58:33 PM |
4 | Latest Telkonet Inc (TKOI) Headlines Telkonet | Stock_Tracker | 03/11/2014 7:23:41 PM |
3 | TKOI 0.26 Stock Charts $TKOI 1 Month Chart | chartguy89 | 03/10/2014 6:20:51 AM |
2 | TKOI Stock Charts Last: +0.001 Sunday, March 2, | chartguy89 | 03/02/2014 12:31:31 AM |
1 | Do not overlook TELKONET ... | JCM | 03/24/2013 11:41:10 PM |
Recent Articles
- Innovative TIL Manufacturing Process Unveiled by Juncell Therapeutics
- Join Class Action: Lead Securities Fraud Against PPTA
- Understanding the Recent Class Action Filed Against SoundHound AI
- Kansas City Life Insurance Announces Quarterly Dividend Update
- Harbinger Launches Innovative Hybrid Vehicle for Fleets
- Fountain Asset Corp Reports Strong Recovery and Future Growth
- GBank Financial Holdings Inc. Celebrates Nasdaq Uplisting Journey
- Investors of Firsthand Technology Have Legal Options Available
- Canopy Growth Faces Class Action Lawsuit Over Securities Fraud
- Class Action Filed Against Quantum Computing Inc. - QUBT Insights
- Class Action Filed Against Sana Biotechnology – Investor Update
- Gerdau S.A. Posts Strong 1Q25 Results with Strategic Plans
- Lyn Cobley Joins Mesoblast Board: A New Era in Leadership
- Oroco Resource Corp. Secures Final Shelf Prospectus Approval
- Celebrating Wukchumni Elder at Upcoming Rock Art Event
- Investigating Claims Against Daktronics: What Investors Need to Know
- Pony AI Inc. Investigation: What Investors Need to Know
- Investigation into Claims Against Xponential Fitness Inc. XPOF
- Investigating KinderCare Learning Companies, Inc. Investor Claims
- Investors Urged to Monitor RH Amid Claims Investigation
- Concerns Arise Over Allegations Against Affirm Holdings, Inc.
- Investigation into Bitfarms Ltd. Promises Investor Insights
- BD&J Law Firm Expands Leadership with New Junior Partners
- Legal Investigation Involving OSI Systems: Insights and Updates
- Investigation Launched into Allbirds, Inc. Stock Concerns
- Take Action: Join the Fluence Energy Lawsuit for Justice
- Fury Gold Mines Strengthens Position with Strategic Acquisition
- Grupo Bafar's Q1 2025 Financial Performance Highlighted by Growth
- Understanding the Securities Class Action for Eldorado Gold
- Mark Hensley's Leadership Role at Heron Therapeutics Unveiled
- Important Update for e.l.f. Beauty, Inc. Investors on Legal Action
- LG Energy Solution's Sustainable Battery Recycling Vision
- LG Energy Solution and Derichebourg Join Forces for Battery Recycling
- Cerevel Therapeutics Investors May Seek Justice in Lawsuit
- Energizer Holdings, Inc. Announces Quarterly Dividend Payout
- ICU Medical Faces Investigation Over Potential Securities Fraud
- Record-Breaking Fundraising Achievements for Children's Causes
- Critical Updates for Avis Budget Group Investors Amid Lawsuit
- Maximizing Comfort and Style in Small Bathroom Renovations
- FTX Takes Legal Steps to Recover Unreturned Tokens and Coins
- Investigation into iRobot Corporation's Securities Practices
- SEEM to Host Board Meeting and Annual Stakeholder Gathering
- Class Action Filed Against Geron Corporation for Misleading Info
- Class Action Filed Against Avis Budget Group Over Fleet Issues
- e.l.f. Beauty Faces Class Action Lawsuit Over Financial Claims
- SEC Investigation Into NET Power Inc: What Investors Need to Know
- BigBear.ai Faces Investigation Amidst Financial Restatement Concerns
- Investors Urged to Join AppLovin Corporation Securities Lawsuit
- Investors Can Take Action in Everus Construction Lawsuit
- Telix Pharmaceuticals Secures Approval for Illuccix in France